{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:51Z","timestamp":1792784331841,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060538; No. 82060543"],"award-info":[{"award-number":["No. 82060538; No. 82060543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["No. 202205AC160008"],"award-info":[{"award-number":["No. 202205AC160008"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["No. 2023535D10"],"award-info":[{"award-number":["No. 2023535D10"]}],"id":[{"id":"https:\/\/ror.org\/02g01ht84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]},{"name":"The Key Project of Yunnan Applied Basic Research","award":["No. 202301AS070061"],"award-info":[{"award-number":["No. 202301AS070061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03942-w","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:38:32Z","timestamp":1719967112000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immune checkpoint inhibitors-induced diabetes mellitus (review)"],"prefix":"10.1007","volume":"86","author":[{"given":"Jiayi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingge","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"issue":"6","key":"3942_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S2213-8587(19)30072-5","volume":"7","author":"AL Perdigoto","year":"2019","unstructured":"A.L. Perdigoto, Z. Quandt, M. Anderson, K.C. Herold, Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome. Lancet Diabetes Endocrinol. 7(6), 421\u2013423 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(19)30072-5.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"3942_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.eprac.2020.12.009","volume":"27","author":"K Shimada","year":"2021","unstructured":"K. Shimada, H. Yamamoto, E. Nakatani et al. Real-world evidence of the incidence of and risk factors for type 1 diabetes mellitus and hypothyroidism as immune-related adverse events associated with programmed cell death-1 inhibitors. Endocr. Pract. 27(6), 586\u2013593 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2020.12.009.","journal-title":"Endocr. Pract."},{"issue":"8","key":"3942_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dbi18-0002","volume":"67","author":"AM Stamatouli","year":"2018","unstructured":"A.M. Stamatouli, Z. Quandt, A.L. Perdigoto et al. Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8), 1471\u20131480 (2018). https:\/\/doi.org\/10.2337\/dbi18-0002.","journal-title":"Diabetes"},{"issue":"1","key":"3942_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1091-2","volume":"18","author":"S Qin","year":"2019","unstructured":"S. Qin, L. Xu, M. Yi, S. Yu, K. Wu, S. Luo, Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol. Cancer. 18(1), 155 (2019). https:\/\/doi.org\/10.1186\/s12943-019-1091-2.","journal-title":"Mol. Cancer."},{"issue":"4","key":"3942_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11523-020-00738-6","volume":"15","author":"E Raschi","year":"2020","unstructured":"E. Raschi, M. Gatti, F. Gelsomino, A. Ardizzoni, E. Poluzzi, F. De Ponti, Lessons to be learnt from real-world studies on immune-related adverse events with checkpoint inhibitors: a clinical perspective from pharmacovigilance. Target Oncol. 15(4), 449\u2013466 (2020). https:\/\/doi.org\/10.1007\/s11523-020-00738-6.","journal-title":"Target Oncol."},{"issue":"1","key":"3942_CR6","doi-asserted-by":"publisher","first-page":"e245846","DOI":"10.1136\/bcr-2021-245846","volume":"15","author":"A Zand Irani","year":"2022","unstructured":"A. Zand Irani, A. Almuwais, H. Gibbons, Immune checkpoint inhibitor-induced diabetes mellitus with pembrolizumab. BMJ Case Rep. 15(1), e245846 (2022). https:\/\/doi.org\/10.1136\/bcr-2021-245846.","journal-title":"BMJ Case Rep."},{"issue":"4","key":"3942_CR7","doi-asserted-by":"publisher","first-page":"e253696","DOI":"10.1136\/bcr-2022-253696","volume":"16","author":"A Zand Irani","year":"2023","unstructured":"A. Zand Irani, H. Gibbons, I. WX, Immune checkpoint inhibitor-induced diabetes mellitus with nivolumab. BMJ Case Rep. 16(4), e253696 (2023). https:\/\/doi.org\/10.1136\/bcr-2022-253696.","journal-title":"BMJ Case Rep."},{"issue":"14","key":"3942_CR8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2169\/internalmedicine.9518-17","volume":"57","author":"M Shiba","year":"2018","unstructured":"M. Shiba, H. Inaba, H. Ariyasu et al. Fulminant type 1 diabetes mellitus accompanied by positive conversion of anti-insulin antibody after the administration of anti-CTLA-4 antibody following the discontinuation of Anti-PD-1 antibody. Intern. Med. 57(14), 2029\u20132034 (2018). https:\/\/doi.org\/10.2169\/internalmedicine.9518-17.","journal-title":"Intern. Med."},{"issue":"1","key":"3942_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0467-z","volume":"19","author":"M Zezza","year":"2019","unstructured":"M. Zezza, C. Kosinski, C. Mekoguem et al. Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports. BMC Endocr. Disord. 19(1), 144 (2019). https:\/\/doi.org\/10.1186\/s12902-019-0467-z.","journal-title":"BMC Endocr. Disord."},{"issue":"6","key":"3942_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/pcmr.12607","volume":"30","author":"PY Chan","year":"2017","unstructured":"P.Y. Chan, P. Hall, G. Hay, V.M.L. Cohen, P.W. Szlosarek, A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity. Pigment. Cell Melanoma Res. 30(6), 558\u2013562 (2017). https:\/\/doi.org\/10.1111\/pcmr.12607.","journal-title":"Pigment. Cell Melanoma Res."},{"issue":"11","key":"3942_CR11","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1210\/jc.2019-00423","volume":"104","author":"VHM Tsang","year":"2019","unstructured":"V.H.M. Tsang, R.T. McGrath, R.J. Clifton-Bligh et al. Checkpoint inhibitor-associated autoimmune diabetes is distinct from type 1 diabetes. J. Clin. Endocrinol. Metab. 104(11), 5499\u20135506 (2019). https:\/\/doi.org\/10.1210\/jc.2019-00423.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3942_CR12","doi-asserted-by":"publisher","first-page":"e000591","DOI":"10.1136\/bmjdrc-2018-000591","volume":"7","author":"A Kotwal","year":"2019","unstructured":"A. Kotwal, C. Haddox, M. Block, Y.C. Kudva, Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes. BMJ Open Diabetes Res. Care. 7(1), e000591 (2019). https:\/\/doi.org\/10.1136\/bmjdrc-2018-000591.","journal-title":"BMJ Open Diabetes Res. Care."},{"issue":"5","key":"3942_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc21-2213","volume":"45","author":"X Chen","year":"2022","unstructured":"X. Chen, A.H. Affinati, Y. Lee, A.F. Turcu, N.L. Henry, E. Schiopu, A. Qin, M. Othus, D. Clauw, N. Ramnath, L. Zhao, Immune checkpoint inhibitors and risk of type 1 diabetes. Diabetes Care. 45(5), 1170\u20131176 (2022). https:\/\/doi.org\/10.2337\/dc21-2213.","journal-title":"Diabetes Care."},{"issue":"12","key":"3942_CR14","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.2337\/dc20-0609","volume":"43","author":"DJ Byun","year":"2020","unstructured":"D.J. Byun, R. Braunstein, J. Flynn, J. Zheng, R.A. Lefkowitz, S. Kanbour, M. Girotra, Immune checkpoint inhibitor-associated diabetes: a single-institution experience. Diabetes Care. 43(12), 3106\u20133109 (2020). https:\/\/doi.org\/10.2337\/dc20-0609.","journal-title":"Diabetes Care."},{"key":"3942_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","volume":"66","author":"JA Pearson","year":"2016","unstructured":"J.A. Pearson, F.S. Wong, L. Wen, The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J. Autoimmun. 66, 76\u201388 (2016). https:\/\/doi.org\/10.1016\/j.jaut.2015.08.019.","journal-title":"J. Autoimmun."},{"issue":"4","key":"3942_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.20051776","volume":"203","author":"ME Keir","year":"2006","unstructured":"M.E. Keir, S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, L.A. Albacker, M. Koulmanda, G.J. Freeman, M.H. Sayegh, A.H. Sharpe, Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203(4), 883\u2013895 (2006). https:\/\/doi.org\/10.1084\/jem.20051776.","journal-title":"J. Exp. Med."},{"issue":"3","key":"3942_CR17","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.diabet.2020.09.003","volume":"47","author":"N Youssef","year":"2021","unstructured":"N. Youssef, M. Noureldein, G. Daoud, A.A. Eid, Immune checkpoint inhibitors and diabetes: Mechanisms and predictors. Diabetes Metab. 47(3), 101193 (2021). https:\/\/doi.org\/10.1016\/j.diabet.2020.09.003.","journal-title":"Diabetes Metab."},{"issue":"1","key":"3942_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJ Ansari","year":"2003","unstructured":"M.J. Ansari, A.D. Salama, T. Chitnis, R.N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S.J. Khoury, H. Auchincloss Jr, M.H. Sayegh, The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198(1), 63\u201369 (2003). https:\/\/doi.org\/10.1084\/jem.20022125.","journal-title":"J. Exp. Med."},{"issue":"11","key":"3942_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s12272-010-1115-3","volume":"33","author":"TJ Won","year":"2010","unstructured":"T.J. Won, Y.J. Jung, S.J. Kwon, Y.J. Lee, D.I. Lee, H. Min, E.S. Park, S.S. Joo, K.W. Hwang, Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes. Arch. Pharm. Res. 33(11), 1825\u20131833 (2010). https:\/\/doi.org\/10.1007\/s12272-010-1115-3.","journal-title":"Arch. Pharm. Res."},{"issue":"9","key":"3942_CR20","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.4049\/jimmunol.179.9.5760","volume":"179","author":"J Cantor","year":"2007","unstructured":"J. Cantor, K. Haskins, Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J. Immunol. 179(9), 5760\u20135767 (2007). https:\/\/doi.org\/10.4049\/jimmunol.179.9.5760.","journal-title":"J. Immunol."},{"issue":"8","key":"3942_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.autrev.2009.02.014","volume":"8","author":"N Alonso","year":"2009","unstructured":"N. Alonso, B. Soldevila, A. Sanmart\u00ed, R. Pujol-Borrell, E. Mart\u00ednez-C\u00e1ceres, Regulatory T cells in diabetes and gastritis. Autoimmun. Rev. 8(8), 659\u2013662 (2009). https:\/\/doi.org\/10.1016\/j.autrev.2009.02.014.","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"3942_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3390\/ijms22042093","volume":"22","author":"D Mourad","year":"2021","unstructured":"D. Mourad, N.S. Azar, A.A. Eid, S.T. Azar, Immune checkpoint inhibitor-induced diabetes mellitus: potential role of t cells in the underlying mechanism. Int. J. Mol. Sci. 22(4), 2093 (2021). https:\/\/doi.org\/10.3390\/ijms22042093.","journal-title":"Int. J. Mol. Sci."},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","volume":"64","author":"JA Noble","year":"2015","unstructured":"J.A. Noble, Immunogenetics of type 1 diabetes: a comprehensive review. J. Autoimmun. 64, 101\u2013112 (2015). https:\/\/doi.org\/10.1016\/j.jaut.2015.07.014.","journal-title":"J. Autoimmun."},{"issue":"4","key":"3942_CR24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"H. Erlich, A.M. Valdes, J. Noble, J.A. Carlson, M. Varney, P. Concannon et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57(4), 1084\u20131092 (2008). https:\/\/doi.org\/10.2337\/db07-1331.","journal-title":"Diabetes"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"1164120","DOI":"10.3389\/fimmu.2023.1164120","volume":"14","author":"YC Liu","year":"2023","unstructured":"Y.C. Liu, H. Liu, S.L. Zhao, K. Chen, P. Jin, Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China. Front. Immunol. 14, 1164120 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1164120.","journal-title":"Front. Immunol."},{"issue":"2","key":"3942_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11154-020-09618-w","volume":"22","author":"V Lo Preiato","year":"2021","unstructured":"V. Lo Preiato, S. Salvagni, C. Ricci, A. Ardizzoni, U. Pagotto, C. Pelusi, Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature. Rev. Endocr. Metab. Disord. 22(2), 337\u2013349 (2021). https:\/\/doi.org\/10.1007\/s11154-020-09618-w.","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"3942_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1159\/000480634","volume":"10","author":"J Kapke","year":"2017","unstructured":"J. Kapke, Z. Shaheen, D. Kilari, P. Knudson, S. Wong, Immune checkpoint inhibitor-associated type 1 diabetes mellitus: case series, review of the Literature, and optimal management. Case Rep. Oncol. 10(3), 897\u2013909 (2017).","journal-title":"Case Rep. Oncol."},{"issue":"2","key":"3942_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1620\/tjem.239.155","volume":"239","author":"Y Miyoshi","year":"2016","unstructured":"Y. Miyoshi, O. Ogawa, Y. Oyama, Nivolumab, an anti-programmed cell Death-1 antibody, induces fulminant type 1 diabetes. Tohoku J. Exp. Med. 239(2), 155\u2013158 (2016).","journal-title":"Tohoku J. Exp. Med."},{"key":"3942_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4172\/2165-7920.1000883","volume":"6","author":"A Fukui","year":"2016","unstructured":"A. Fukui, K. Sugiyama, T. Yamada, A case of nivolumab-induced fulminant type 1 diabetes with steroids and glucagon-like peptide 1 administration during the early onset. J. Clin. Case Rep. 6, 11 (2016).","journal-title":"J. Clin. Case Rep."},{"key":"3942_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40425-016-0196-z","volume":"4","author":"JR Lowe","year":"2016","unstructured":"J.R. Lowe, D.J. Perry, A.K. Salama, C.E. Mathews, L.G. Moss, B.A. Hanks, Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy. J. Immunother Cancer. 4, 89 (2016). https:\/\/doi.org\/10.1186\/s40425-016-0196-z.","journal-title":"J. Immunother Cancer."},{"key":"3942_CR31","doi-asserted-by":"publisher","first-page":"764138","DOI":"10.3389\/fendo.2021.764138","volume":"12","author":"VHM L, Tsang","year":"2021","unstructured":"V.H.M. L, Tsang, S.C. Sasson, A.M. Menzies, M.S. Carlino, D.A. Brown, R. Clifton-Bligh, J.E. Gunton, Unravelling checkpoint inhibitor associated autoimmune diabetes: from bench to bedside. Front. Endocrinol. 12, 764138 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.764138.","journal-title":"Front. Endocrinol."},{"key":"3942_CR32","doi-asserted-by":"publisher","first-page":"869204","DOI":"10.3389\/fendo.2022.869204","volume":"13","author":"J Suh","year":"2022","unstructured":"J. Suh, H.I. Lee, M. Lee, K. Song, H.S. Choi, A. Kwon, H.S. Kim, H.W. Chae, Insulin requirement and complications associated with serum C-peptide decline in patients with type 1 diabetes mellitus during 15 years after diagnosis. Front. Endocrinol. 13, 869204 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.869204.","journal-title":"Front. Endocrinol."},{"issue":"35","key":"3942_CR33","doi-asserted-by":"publisher","first-page":"e30456","DOI":"10.1097\/MD.0000000000030456","volume":"101","author":"JH Seo","year":"2022","unstructured":"J.H. Seo, T. Lim, A. Ham, Y.A. Kim, M. Lee, New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: a case report. Medicine 101(35), e30456 (2022). https:\/\/doi.org\/10.1097\/MD.0000000000030456.","journal-title":"Medicine"},{"key":"3942_CR34","doi-asserted-by":"publisher","unstructured":"Phang C.A., Kumar S., Rohl P. Acute presentation of immunotherapy-related diabetes mellitus without ketoacidosis, low C-peptide or elevated HbA1c. Endocrinol Diabetes Metab Case Rep. Published online November 1, 2022. https:\/\/doi.org\/10.1530\/EDM-22-0291.","DOI":"10.1530\/EDM-22-0291"},{"key":"3942_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fendo.2019.00352","volume":"10","author":"J Sothornwit","year":"2019","unstructured":"J. Sothornwit, A. Phunmanee, C. Pongchaiyakul, Atezolizumab-induced autoimmune diabetes in a patient with metastatic lung cancer. Front Endocrinol. 10, 352 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00352.","journal-title":"Front Endocrinol."},{"issue":"11","key":"3942_CR36","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.2337\/db10-0676","volume":"59","author":"HA Keenan","year":"2010","unstructured":"H.A. Keenan, J.K. Sun, J. Levine, A. Doria, L.P. Aiello, G. Eisenbarth, S. Bonner-Weir, G.L. King, Residual insulin production and pancreatic \u00df-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes. 59(11), 2846\u20132853 (2010). https:\/\/doi.org\/10.2337\/db10-0676.","journal-title":"Diabetes."},{"issue":"7292","key":"3942_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nature08894","volume":"464","author":"F Thorel","year":"2010","unstructured":"F. Thorel, V. N\u00e9pote, I. Avril, K. Kohno, R. Desgraz, S. Chera, P.L. Herrera, Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature. 464(7292), 1149\u20131154 (2010). https:\/\/doi.org\/10.1038\/nature08894.","journal-title":"Nature."},{"key":"3942_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2013.00201","volume":"4","author":"AM Dimarino","year":"2013","unstructured":"A.M. Dimarino, A.I. Caplan, T.L. Bonfield, Mesenchymal stem cells in tissue repair. Front Immunol. 4, 201 (2013). https:\/\/doi.org\/10.3389\/fimmu.2013.00201.","journal-title":"Front Immunol."},{"issue":"7","key":"3942_CR39","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2337\/db08-0180","volume":"57","author":"R Abdi","year":"2008","unstructured":"R. Abdi, P. Fiorina, C.N. Adra, M. Atkinson, M.H. Sayegh, Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57(7), 1759\u20131767 (2008). https:\/\/doi.org\/10.2337\/db08-0180.","journal-title":"Diabetes."},{"issue":"7","key":"3942_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-022-05708-3","volume":"65","author":"E Kawada-Horitani","year":"2022","unstructured":"E. Kawada-Horitani, S. Kita, T. Okita, Y. Nakamura, H. Nishida, Y. Honma, S. Fukuda, Y. Tsugawa-Shimizu, J. Kozawa, T. Sakaue, Y. Kawachi, Y. Fujishima, H. Nishizawa, M. Azuma, N. Maeda, I. Shimomura, Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade. Diabetologia. 65(7), 1185\u20131197 (2022). https:\/\/doi.org\/10.1007\/s00125-022-05708-3.","journal-title":"Diabetologia."},{"issue":"8","key":"3942_CR41","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"P.O. Carlsson, D. Espes, S. Sisay, L.C. Davies, C.I.E. Smith, M.G. Svahn, Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II andomized double-blind placebo-controlled trial. Diabetologia. 66(8), 1431\u20131441 (2023). https:\/\/doi.org\/10.1007\/s00125-023-05934-3.","journal-title":"Diabetologia."},{"issue":"8","key":"3942_CR42","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"P.O. Carlsson, D. Espes, S. Sisay, L.C. Davies, C.I.E. Smith, M.G. Svahn, Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial. Diabetologia. 66(8), 1431\u20131441 (2023). https:\/\/doi.org\/10.1007\/s00125-023-05934-3.","journal-title":"Diabetologia."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03942-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03942-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03942-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T07:33:06Z","timestamp":1729236786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03942-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03942-w","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}